Norges Bank
YMAB

Norges Bank’s Y-mAbs Therapeutics YMAB Stock Holding History

Norges Bank’s Portfolio YMAB Stock Details YMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-22,500
Closed -$864K – 2170
2020
Q3 		$864K Buy
+22,500
New +$895K ﹤0.01% 2046
2018
Q4 		– Sell
-15,000
Closed -$398K – 2136
2018
Q3 		$398K Buy
+15,000
New +$381K ﹤0.01% 2106

Other funds holding YMAB

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Norges Bank's YMAB Position: Q4 2020 in Review

Norges Bank sold out of Y-mAbs Therapeutics (YMAB) in Q4 2020, closing a stake of 22,500 shares — an estimated $864K sold.

Norges Bank first reported a position in YMAB in Q3 2018 and held it in 2 quarters. The position peaked at $864K in Q3 2020. 114 funds tracked by Wall St. Rank hold YMAB as of Q4 2020.

  • Norges Bank reported no remaining Y-mAbs Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Norges Bank sold 22,500 Y-mAbs Therapeutics shares in Q4 2020, an estimated $864K.
  • Norges Bank first reported a position in Y-mAbs Therapeutics in Q3 2018 and held it in 2 quarters.
  • Norges Bank's Y-mAbs Therapeutics position peaked at $864K in Q3 2020.
  • 114 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q4 2020.

Based on Norges Bank's 13F filing for Q4 2020, filed 10 Feb 2021.